UNII - 1Q2QT5M7EO

BALSTILIMAB

UNII: 1Q2QT5M7EO

Preferred Substance Name: BALSTILIMAB

2148321-77-9
A FULLY HUMAN IGG4 MONOCLONAL ANTAGONIST ANTIBODY DIRECTED AGAINST PROGRAMME D CELL DEATH PROTEIN 1 (PD-1) WITH POTENTIAL IMMUNE CHECKPOINT INHIBITORY AND ANTINEOPLASTIC ACTIVITIES
AGEN2034
AGEN-2034
ANTI-PD1 MONOCLONAL ANTIBODY AGEN2034
BALSTILIMAB [INN]
BALSTILIMAB [USAN]
BALSTILIMAB [WHO-DD]
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL AGEN2034 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AGEN2034 .KAPPA.-CHAIN, DIMER

Common Chemistry
i
Inxight Drugs
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BALSTILIMAB

Synonyms and Mappings

Resources

Note